Prawo i regulacje · 23/01/2015
Federal Judge Approves Pfizer's Acquisition of BioNTech, Valued at $68 Billion
US District Judge Jose Raul S. Villavicencio has approved Pfizer's $68 billion acquisition of BioNTech, a German biotechnology company that developed the COVID-19 vaccine